TNYA - Tenaya Therapeutics, Inc.

QQQ $ 422.86 $ 1.84 (0.44 %)

DIA $ 379.94 $ -4.50 (-1.17 %)

SPY $ 502.01 $ -0.25 (-0.05 %)

TLT $ 87.76 $ -0.17 (-0.19 %)

GLD $ 215.45 $ 0.11 (0.05 %)

Previous Close

$ 4.38

Open

$ 4.20

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 4.00 - $ 4.24

52 Week Range

$ 1.66 - $ 8.09

Volume

321,384

Average Volume

Market Cap

323.18M

Beta (5Y Monthly)

$ 2.41

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-18-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-09-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	03-08-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-10-2022	06-30-2022	10-Q
8	05-11-2022	03-31-2022	10-Q
9	03-23-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	09-08-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Chardan Capital Reiterates Buy on Tenaya T...
03/21/2024 16:52:30

Chardan Capital analyst Geulah Livshits reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $20 price target.

Canaccord Genuity Maintains Buy on Tenaya ...
03/20/2024 11:44:10

Canaccord Genuity analyst Whitney Ijem maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and lowers the price target fr...

HC Wainwright & Co. Reiterates Buy on Tena...
03/19/2024 11:09:57

HC Wainwright & Co. analyst Joseph Pantginis reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $18 p...

Tenaya Therapeutics Q4 EPS $(0.40) Beats $...
03/18/2024 20:09:03

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $...

Tenaya Therapeutics Publishes TN-401 Gene ...
03/18/2024 12:34:06

TN-401 AAV9-Based Gene Therapy Being Developed to Treat the Underlying Cause of PKP2-associated Arrhythmogenic Right Ventricula...

blend-labs-reports-q4-results-joins-alta-equipment-despegarcom-and-other-big-stocks-moving-higher-on-friday

Blend Labs Reports Q4 Results, Joins Alta ...
03/15/2024 14:25:26

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ: BLN...

$tenaya-therapeutics-publishes-preclinical-hdac6-inhibitor-data-for-heart-failure-with-preserved-ejection-fraction-in-nature-communications$

Tenaya Therapeutics Publishes Preclinical ...
02/26/2024 13:43:22

Highly selective Small Molecule HDAC6 Inhibitor Effectively Reversed Heart Failure and Improved Diastolic Heart Function Alone ...

Why Fluor Shares Are Trading Lower By Arou...
02/20/2024 18:21:11

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
02/20/2024 17:31:11

Tenaya Therapeutics Announces Pricing Of $...
02/08/2024 13:04:45

Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

why-commscope-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-mondays-mid-day-session

Why CommScope Shares Are Trading Lower By ...
01/22/2024 18:08:22

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal L...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
01/19/2024 17:31:10

12 Health Care Stocks Moving In Tuesday's ...
12/19/2023 17:32:31

Leerink Partners Initiates Coverage On Ten...
11/30/2023 13:46:03

Leerink Partners analyst Mani Foroohar initiates coverage on Tenaya Therapeutics (NASDAQ:TNYA) with a Outperform rating and ...

Tenaya Therapeutics Q3 EPS $(0.39) Beats $...
11/08/2023 22:17:38

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $...

Tenaya Therapeutics Announces FDA Clearanc...
10/26/2023 12:36:16

PKP2 Mutations Are the Leading Cause of ARVC, a Dangerous Condition Linked to Sudden Cardiac Arrest in Young People Estimated t...

$tenaya-therapeutics-presents-new-clinical-and-preclinical-data-from-hdac6-inhibitor-program-tn-301-for-the-potential-treatment-of-heart-failure-with-preserved-ejection-fraction-at-the-2023-hfsa-annual-scientific-meeting$

Tenaya Therapeutics Presents New Clinical ...
10/09/2023 12:42:08

TN-301 Demonstrates Tolerability, Potential for Once Daily Dosing, Target Engagement and Selectivity for HDAC6 in Phase 1 Clini...

Expert Ratings for Tenaya Therapeutics
10/09/2023 12:00:57

HC Wainwright & Co. Reiterates Buy on Tena...
10/09/2023 10:26:53

HC Wainwright & Co. analyst Joseph Pantginis reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $18 p...

Tenaya Therapeutics Doses First Patient In...
10/05/2023 12:34:13